{"id":"clm_977F9FBD1ED5","entity":"pfizer","predicate":"total_equity","value":"71,319,000,000 United States dollar","value_json":{"fp":"Q3","fy":2018,"accn":"0000078003-18-000091","form":"10-Q","filed":"2018-11-08","period":"Q3 FY2018","concept":"us-gaap:StockholdersEquity"},"valid_from":"2018-09-30","valid_to":"2018-12-31","published":"2018-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Pfizer total equity: 71,319,000,000 United States dollar\", as of 2018-09-30 (until 2018-12-31). Claim clm_977F9FBD1ED5, https://asof.is/claim/clm_977F9FBD1ED5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/78003/000007800318000091/0000078003-18-000091-index.htm.","url":"https://asof.is/claim/clm_977F9FBD1ED5","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6C92A8E3F7CA","supersedes":["clm_FE5D7E2D1CFF"],"first_seen_at":"2026-11-08T16:58:25.959946+00:00","updated_at":"2026-11-08T16:58:29.361836+00:00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/78003/000007800318000091/0000078003-18-000091-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2018","published_at":"2018-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2018, filed 2018-11-08"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}